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Anatomy and physiology of adrenal glands
Adrenal cortex produces three major classes of steroids 
 all derived from cholesterol 
◦ mineralocorticoids (aldosterone) from zona 
glomerulosa (outermost layer = “salt”)
◦ glucocorticoids (cortisol) from zona fasciculata
(middle layer = “sugar”)
◦ androgens from zona reticularis (innermost layer = 
“sex”) 
www.slideshare.net/…nmn/oxford-american-handbook...
Anatomy and physiology of adrenal glands
What effects of glucocorticoids  do you  
know?
How are they regulated?
Anatomy and physiology of adrenal glands: 
effects of GCSs
• stimulate hepatic glucose production (gluconeogenesis)
• increase insulin resistance in peripheral tissues
• increase protein catabolism
• cause leukocytosis and lymphopenia
• inhibit bone formation; stimulate bone resorption
• inhibit fibroblasts, causing collagen and connective tissue 
loss
• suppress inflammation; impair cell-mediated immunity
• regulate extracellular fluid volume; promote renal solute-
free water clearance
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Anatomy and physiology of adrenal glands: 
secretion of GCSs is regulated by ACTH
• diurnal variation of ACTH (higher in a.m. than p.m., with 
peak around 02.00 hours)
• inhibition of both ACTH and CRH release (negative 
feedback)
• stress (e.g. fever, pain, hypoglycemia), in addition to 
stimulating ACTH release,
directly stimulates CRH release, over-riding diurnal variation 
and negative feedback
 10% free in plasma, 90% bound to transcortin (inactive)
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Anatomy and physiology of adrenal glands
What effects of mineralocorticoids do you  
know?
How are they regulated?
Anatomy and physiology of adrenal glands: 
aldosterone
• regulates extracellular fluid (ECF) volume through Na+ 
retention and K+ excretion (by stimulation of distal tubule 
Na+/K+ ATPase)
Anatomy and physiology of adrenal glands
 Mineralocorticoid (aldosterone 100–150 mcg/day) 
synthesis occurs in zona glomerulosa predominantly 
under the control of the renin–angiotensin system, 
although ACTH also contributes to its regulation
• aldosterone regulated principally by the renin-angiotensin-
aldosterone system
• negative feedback to juxtaglomerular apparatus by long loop 
(aldosterone via volume expansion) and short loop (angiotensin 
II via peripheral vasoconstriction)
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Anatomy and physiology of adrenal glands
What effects of androgens do you  know?
How are they regulated?
Anatomy and physiology of adrenal glands
 Adrenal gland (zona reticularis and zona fasciculata) also 
produces  sex steroids, in the form of dehydroepi-
androstenedione (DHEA), androstenedione and 11-
hydroxyandrostenedione
• peak concentrations in puberty
• proportion of total androgens (adrenal to gonadal) 
increases in old age
• primarily responsible for adrenarche (pubic and axillary 
hair) 
• adrenal androgen formation is regulated by ACTH (not LH)
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Anatomy and physiology of adrenal glands
• Urinary steroid profiling provides quantitative 
information on the  biosynthetic and catabolic 
pathways
Profiling can be useful in the following:  
o Mineralocorticoid hypertension 
o Polycystic ovary syndrome 
o Congenital adrenal hyperplasia 
o Steroid-producing tumors 
o Precocious puberty and virilization
o Hirsutism
www.slideshare.net/…nmn/oxford-american-handbook...
1) Chronic insufficiency of adrenal 
glands
1) Chronic insufficiency of adrenal glands:
Primary (Addison’s Disease)
 rare form of adrenal pathology
 most cases are idiopathic
◦ • likely autoimmune destruction of adrenals (50% of 
patients
◦ have circulating adrenal antibodies)
◦ • high association with other autoimmune diseases (e.g. 
chronic lymphocytic thyroiditis,
◦ type 1 DM, vitiligo, pernicious anemia)
 metastatic tumour - second commonest cause
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1) Chronic insufficiency of adrenal glands:
Primary (Addison’s Disease) (cont’d)
 hemorrhagic infarction - coagulopathy in adults or 
Waterhouse-Friderichsen syndrome in children 
(meningococcal or Pseudomonas septicemia)
 adrenalectomy
 granulomatous disease (e.g. TB, sarcoidosis)
 infection - particularly AIDS
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1) Chronic insufficiency of adrenal glands:
Secondary
 inadequate pituitary ACTH secretion
 multiple etiologies (Hypopituitarism), including 
withdrawal of
 exogenous steroids that have suppressed pituitary ACTH 
production
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1) Chronic insufficiency of adrenal glands:
Clinical Features
both primary and secondary
 weakness and fatigue
 postural hypotension
 weight loss, anorexia, nausea/vomiting, diarrhea
 abdominal, muscle, and joint pain
primary
 hyperpigmentation of skin and mucous membranes 
(e.g. palmar creases and buccal mucosa)
 dehydration, salt craving
secondary
 usually more chronic than primary
 pallor, normal K+ and hydration
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1) Chronic insufficiency of adrenal glands:
Laboratory Findings
 hyponatremia, hyperkalemia, elevated BUN/creatinine
 chronic anemia (normochromic, normocytic)
primary
 low cortisol unresponsive to exogenous ACTH
 high ACTH
 adrenal antibodies if autoimmune etiology
secondary
 low cortisol, low ACTH
 usually normal K+, BUN/creatinine
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1) Chronic insufficiency of adrenal glands:
What is Addison’s disease?
1) Chronic insufficiency of adrenal glands:
Addison’s disease
Addison’s disease (also chronic
adrenal insufficiency, primary
adrenocortical insufficiency,
hypocortisolism, and hypoadrenalism)
is a rare, chronic endocrine disorder in
which the adrenal glands do not
produce sufficient steroid hormones
(glucocorticoids and often
mineralocorticoids)
This is a rare condition with an estimated
incidence in the developed world of 0.8 cases
per 100,000 and prevalence of 4 to 11 cases
per 100,000 population
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
1) Chronic insufficiency of adrenal glands:
Etiology of and risk factors for Addison’s 
disease   
1) Chronic insufficiency of adrenal glands:
Addison’s disease. Etiology and risk factors
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
1) Chronic insufficiency of adrenal glands:
Addison’s disease     Etiology and risk factors
↑glycolysis, 
↓gluconeogenesis
Dystrophic changes in 
tissues
↓ protein synthesis, 
immunity
↓Na- dehydration, 
osmolarity, BP
Anorexia, muscles 
atrophy, ↓weight,  
testosteron
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
1) Chronic insufficiency of adrenal glands:
Clinical features of Addison’s disease
1) Chronic insufficiency of adrenal glands:
Addison’s disease. Clinical features
Chronic
 Anorexia and weight loss (>90%)  
 Tiredness  
 Weakness—generalized, no particular muscle groups  
 Pigmentation—generalized, but most common in 
light-exposed areas and areas exposed to pressure 
(elbows and knees, and under bras and belts); mucosa 
and scars acquired after onset of adrenal insufficiency
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
1) Chronic insufficiency of adrenal glands:
Addison’s disease. Clinical features 
Chronic
 Look at palmar creases in Caucasians.  
 Dizziness and postural hypotension  
 GI symptoms—nausea and vomiting, abdominal pain, 
diarrhea  
 Arthralgia and myalgia
 Symptomatic hypoglycemia—rare in adults  
 ↓ Axillary and pubic hair and reduced libido in women  
 Pyrexia of unknown origin—rarely 
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
1) Chronic insufficiency of adrenal glands:
Addison’s disease. Clinical features
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
1) Chronic insufficiency of adrenal glands:
Diagnosis of Addison’s disease
1) Chronic insufficiency of adrenal glands:
Addison’s disease. Diagnosis
Screening recommendations
 2.4% of patients with a monoglandular autoimmune 
endocrinopathy have APS2 on subsequent follow-up.  
 Functional screening is recommended every 3 years until 
the age of 75 years
 Serum Na + , K + , Ca 2+ , blood cell count   
 TSH, free T 4    
 FSH, LH, testosterone, or estradiol
 Fasting morning cortisol and glucose  
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
1) Chronic insufficiency of adrenal glands:
Addison’s disease. Diagnosis
Screening recommendations
 Optional: ACTH stimulation test    
 If a second endocrinopathy is diagnosed, measure organ-
specific  autoantibodies and consider functional screening 
in fi rst-degree relatives
 Islet cells, GAD, IA2 
 TPO, TSH receptor   
 Cytochrome P450 enzymes    
 H + -K + -ATPase of the parietal cells, intrinsic factor    
 Transglutaminase, gliadin
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
1) Chronic insufficiency of adrenal glands: 
Addison’s disease. Diagnosis
CT/MRI imagine
A CT scan may reveal
enlarged or calcified
adrenals, suggesting
an infective,
hemorrhagic, or
malignant diagnosis
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
1) Chronic insufficiency of adrenal glands:
How is   Addison’s disease treated?
1) Chronic insufficiency of adrenal glands: 
Addison’s disease.  Treatment
Maintenance therapy   
Glucocorticoid replacement   
 Hydrocortisone is the treatment of choice for replacement 
therapy, as it  is reliably and predictably absorbed and allows 
biochemical monitoring of levels
 It is administered 3 × daily 10 mg on waking, 5 mg at midday, 
and 5 mg at  6 P.M
 Some patients can be managed adequately with twice-daily 
administration of hydrocortisone
 An alternative is prednisone 5 mg once daily
 This has the disadvantage that levels cannot be biochemically 
monitored, but its longer t½ may lead  to better suppression of 
ACTH if pigmentation and markedly elevated  morning ACTH 
levels are a problem
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
1) Chronic insufficiency of adrenal glands: 
Addison’s disease. Treatment
Mineralocorticoid replacement   
 Fludrocortisone (9-fl  urohydrocortisone) is given at a dose 
of 0.1 mg daily
 Aim to avoid signifi cant postural fall in BP (>10 mmHg) 
 lower (0.05 mg) or higher (0.2 mg) doses are required 
 A dose of 40 mg hydrocortisone has the equivalent 
mineralocortisone effects as 0.1 mg fl  udrocortisone
 Renin activity can help guide adequacy of therapy
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
1) Chronic insufficiency of adrenal glands: 
Addison’s disease.  Treatment
DHEA replacement   
 Dihydroepiandrosterone (DHEA) is also deficient in 
hypoadrenalism
 DHEA replacement (25–50 mg/day) may improve mood 
and well-being (as dietary supplement)
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
1) Chronic insufficiency of adrenal glands: 
Addison’s disease.  Treatment
Monitoring of therapy   
Clinical     
 For signs of glucocorticoid excess, e.g., i weight  
 BP (including postural change)     
 Hypertension and edema suggest excessive 
mineralocorticoid replacement, whereas postural 
hypotension and salt craving suggest insuffi cient
treatment
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
Biochemical     
 Serum electrolytes  
 Plasma renin activity (elevated if insuffi cient fl  
udrocortisone replacement)
 Very dependent on when the last dose was taken  
 Cortisol day curve to assess adequacy of treatment       
Monitor ACTH levels prior to and following morning 
glucocorticoid replacement if the patient develops i
pigmentation
If levels are elevated  or rising with little suppression 
following glucocorticoid, obtain an MRI scan to exclude the 
rare possibility of pituitary hyperplasia or, very rarely, the 
development of a corticotrope adenoma
1) Chronic insufficiency of adrenal glands: 
Addison’s disease.  Treatment
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
2) Hyperfunction of adrenal glands:  
hyperaldosteronism
What causes of mineralocorticoid excess 
(hyperaldosteronism) do you  know?
2)Hyperfunction of adrenal glands:
causes of mineralocorticoid excess
 Most cases of mineralocorticoid excess are due to excess 
aldosterone production, which may be primary or 
secondary, and are typically associated with hypertension 
and hypokalemia
 Primary hyperaldosteronism is a disorder of autonomous 
aldosterone hypersecretion with suppressed renin levels
 Secondary hyperaldosteronism occurs when aldosterone
hypersecretion occurs secondary to elevated circulating 
renin levels
 This is typical of heart  failure, cirrhosis, or nephrotic
syndrome, but can also be due to renal artery  stenosis
and, occasionally, a very rare renin-producing tumor 
(reninoma)
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Primary hyperaldosteronism
 Conn’s syndrome (aldosterone-producing adrenal adenoma): 35%  
 Bilateral adrenal hyperplasia: 60%  
 Glucocorticoid remedial aldosteronism (GRA): <1%  
 Aldosterone-producing adrenal carcinoma 
Secondary hyperaldosteronism increase in aldosterone in response to 
activation of renin-angiotensin system
 overproduction of renin (e.g. primary reninism from renin-producing 
tumour - rare)
 secondary hyperreninism - due to hypoperfusion of kidneys (e.g. 
renal artery stenosis), or edematous states (CHF, liver cirrhosis), 
where arterial hypovolemia and/or hypotension is stimulus for 
aldosterone secretion (Bartter’s syndrome - severe secondary 
hyperaldosteronism without edema or hypertension (due to JGA 
hyperplasia)) or  Renin-secreting tumor 
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2)Hyperfunction of adrenal glands:
causes of mineralocorticoid excess
2)Hyperfunction of adrenal glands: effects of 
mineralocorticoid excess
 Aldosterone causes renal sodium retention and potassium 
loss
 This  results in expansion of body sodium content, leading 
to suppression of  renal renin synthesis
 The direct action of aldosterone on the distal nephron
causes sodium  retention and loss of hydrogen and 
potassium ions, resulting in a hypokalemic alkalosis, 
although serum potassium may not be signifi cantly
reduced  and may be normal in up to 50% of cases
 Aldosterone excess has pathophysiological effects on a 
range of other tissues, causing cardiac fibrosis, vascular 
endothelial dysfunction, and  nephrosclerosis
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2)Hyperfunction of adrenal glands: 
clinical features of mineralocorticoid excess 
 Moderately severe hypertension occurs, which is often 
resistant to conventional therapy
 There may be disproportionate left ventricular hypertrophy
 Hypokalemia OFF diuretics 
 Hypokalemia is usually asymptomatic 
 Occasionally, patients may present with tetany, myopathy, 
polyuria, polydipsia,and nocturia (hypokalemic nephrogenic 
diabetes insipidus), paresthesias due to severe 
hypokalemia
 Other symptoms may include  fatigue, weakness, headaches
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2)Hyperfunction of adrenal glands: 
mineralocorticoid excess  
What is Conn’s syndrome?
2)Hyperfunction of adrenal glands: 
mineralocorticoid excess. Conn’s syndrome 1.1
Conn’s syndrome—aldosterone-producing adrenal 
adenoma   
 Very high levels of the enzyme aldosterone synthase are 
expressed in tumor tissue
 Although aldosterone production is autonomous, ACTH 
has a greater stimulatory effect than angiotensin II 
(aldosterone often displays a diurnal variation that mirrors 
that of cortisol), although a subtype that remain more 
responsive to angiotensin II has been described
 Very rarely, Conn’s adenomas may be a part of the MEN1 
syndrome
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2)Hyperfunction of adrenal glands: 
mineralocorticoid excess. Conn’s syndrome: 
Imaging
Adrenal adenoma:
Axial CT image in (a)
shows hypodense fat
containing mass
(arrow) in the right
adrenal. Axial CT
image in (b) shows a
lipid-poor adenoma
in left adrenal
(arrow) in a patient
with Conn's
syndrome
Adenoma more than 1 cm 
(a) J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 
2015
2) Hyperfunction of adrenal glands: 
mineralocorticoid excess  
What is Bilateral adrenal hyperplasia?
2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Bilateral adrenal 
hyperplasia 
Bilateral adrenal hyperplasia (bilateral idiopathic 
hyperaldosteronism)   
 This is the most common form of primary hyperaldosteronism in 
adults 
 Hyperplasia is more commonly bilateral than unilateral and may be 
associated with micronodular or macronodular hyperplasia
 CT-demonstrable nodules have a prevalence of 2% in the general 
population, including hypertensive patients without excess 
aldosterone production
 The pathophysiology is not known, although aldosterone secretion 
is very sensitive to circulating angiotensin II
 The pathophysiology of bilateral adrenal hyperplasia is not 
understood; it is possible that it represents an extreme end of the 
spectrum of low rennin-essential hypertension
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2) Hyperfunction of adrenal glands: 
mineralocorticoid excess  
Diagnosis of mineralocorticoid excess ?
2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Diagnosis
Screening  
Indications     
 Patients resistant to conventional antihypertensive 
medication (i.e., not controlled on three agents one of 
which is diuretic)  
 Hypertension associated with hypokalemia
(potassium < 3.7 mmol/L, irrespective of thiazide use)  
 Hypertension developing before 40 years of age  
 Adrenal incidentaloma
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2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Diagnosis
Method
 False-negative and false-positive results can occur if 
the test is not performed under controlled 
circumstances  
 Give oral supplements of potassium to control 
hypokalemia
 Stop medication that can interfere with the test using 
appropriate washout period
 Blood pressure (BP) can be controlled using doxazosin
or verapamil (rather than other calcium antagonists)
 Measure aldosterone/renin ratio
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2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Diagnosis
Confirmation of diagnosis   
 Confirmation of autonomous aldosterone production is 
made by demonstrating failure to suppress aldosterone in 
the face of sodium/volume loading
 This can be achieved through a number of mechanisms 
after optimizing test conditions as described
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2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Diagnosis
Dietary sodium loading  
 Patients can be insructed to take a diet with high sodium 
content (suffi cient to raise the sodium intake to 200 
mmol/day for 3 days
 If necessary, this can be achieved by adding supplemental 
sodium chloride tablets 
 It is important to ensure that potassium is maintained 
during this period; potassium supplementation may also be 
required
 Failure to suppress 24-hour urinary aldosterone secretion 
at the end of this period is diagnostic of primary 
aldosteronism
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2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Diagnosis
Saline infusion test     
 Administer 2 L normal saline over 4 hours, preferably 
between  8 A.M. and noon
 Measure plasma aldosterone at 0 and 4 hours
 Aldosterone fails to suppresses to <7.5 ng/mL (7.5–10 
equivocal) in 80–90% of primary aldosteronism
Frequently
this test is followed by measurements of plasma rennin 
activity (PRA) with upright posture and use of a diuretic 
(furosemide up to 80 mg) 
 Low PRA under these conditions supports the diagnosis
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2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Diagnosis
Captopril suppression test     
 Plasma aldosterone is measured in the sitting position, 
basally, and 60 minutes after captopril 25 mg.  
 Inhibition of angiotensin II leads to a fall in aldosterone in 
patients with idiopathic hyperaldosteronism but not in 
Conn’s syndrome    
Fludrocortisone suppression test     
 Give fl  udrocortisone 100 mcg q6h for 4 days 
 Measure aldosterone basally and on last day  
 Aldosterone is suppressed in hyperplasia but unchanged in 
adenomas 
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2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Diagnosis
CT/MRI scan  are of value in identifying adrenal adenomas
That the frequency of adrenal incidentalomas rises with age 
and, for this reason, it is prudent to consider adrenal vein 
sampling in older patients (age >50) with primary 
aldosteronism who have  an apparent solitary adenoma on 
scanning
 Identifies most adenomas >5 mm diameter
 Bilateral abnormalities or  tumors <1 cm in diameter 
require further localization procedures
 In bilateral adrenal hyperplasi,a both glands can appear 
enlarged or  normal in size
 Macronodular hyperplasia may result in identifi able 
nodules on imaging
 A mass >4 cm in size is suspicious of carcinoma but is 
unusual in Conn’s syndrome
 In essential hypertension, nodules are described
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2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Diagnosis
Adrenal vein sampling 
 Aldosterone measurements from both adrenal veins allow 
a gradient  between the two sides to be identified in the 
case of unilateral disease
 It  is the gold standard for differentiation between uni- and 
bilateral aldosterone production, but cannulating the right 
adrenal vein is technically  difficult, as it drains directly into 
the inferior vena cava
 Cortisol measurements must also be taken concomitantly 
with aldosterone to confirm successful positioning within 
the adrenal veins and should be more than 3× a peripheral 
sample (central/peripheral ratio >3)
 The aldosterone/cortisol ratio with an adenoma is >4.1
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2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Diagnosis
Radiolabeled iodocholesterol scanning 
 This test has low sensitivity and specifi city and offers no 
advantage over a high-resolution CT or MRI with, where 
necessary, adrenal vein sampling
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2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. 
Treatment
2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Treatment 
Surgery   
 Laparascopic adrenalectomy
 Surgery is not indicated in patients with idiopathic 
hyperaldosteronism, as even bilateral adrenalectomy may 
not cure the hypertension
 Presurgical spironolactone treatment may be used to 
correct potassium  stores before surgery
 The BP response to treatment with spironolactone (50–400 
mg/day)  before surgery can be used to predict the 
response to surgery of patients  with adenomas
 Hypertension is cured in about 70% of patients If it persists 
(more likely in those with long-standing hypertension and 
increased age), it is more amenable to medical treatment. 
 Overall, 50% become normotensive in 1 month and 70% 
within 1 year
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2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Treatment 
Medical treatment   
 Medical therapy remains an option for patients with a 
solitary adrenaladenoma who are unlikely to be cured by 
surgery, who are unfit for operation, or who express a 
preference for medical management
 The aldosterone antagonist  spironolactone (50–400 
mg/day) has been used successfully for many years to treat 
the hypertension and hypokalemia associated with bilateral 
adrenal hyperplasia and idiopathic hyperaldosteronism
 There may be a delay in response of hypertension of 4–8 
weeks
 Combination with other antihypertensive agents (ACE 
inhibitor and calcium channel blockers) is usually required
 Side effects are common, particularly gynecomastia and 
impotence in men, menstrual irregularities in women, and 
GI effects
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2) Hyperfunction of adrenal glands: 
mineralocorticoid excess. Treatment 
 Eplerenone (50–100 mg/day) is a mineralocorticoid
antagonist without antiandrogen effects and greater 
selectivity than that of spironolactone
 Alternative drugs include the potassium-sparing diuretics  
amiloride and triamterene
 Amiloride may need to be given in high dose (up to 40 
mg/day)  in primary aldosteronism, and monitoring of 
serum potassium is essential  Calcium channel antagonists 
may also be helpful
 Glucocorticoid-remedial aldosteronism can be treated with 
low-dose dexamethasone (0.5 mg on going to bed). Side 
effects often limit therapy,  and spironolactone or amiloride
treatment is often preferred
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2) Hyperfunction of adrenal glands: 
hypercortisolism
What is Cushing’s syndrome?
Definition
2) Hyperfunction of adrenal glands (hypercortisolism) 
Cushing’s syndrome. Definition
Cushing’s syndrome results from chronic 
glucocorticoid excess (endogenous or 
exogenous sources)
2) Hyperfunction of adrenal glands: 
hypercortisolism
Etiology and Classification of Cushing’s   
syndrome 
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
What are the main clinical features of 
hypercortisolism ?
2) Hyperfunction of adrenal glands: 
hypercortisolism
2)Hyperfunction of adrenal glands: 
hypercortisolism. Clinical Features
general
• truncal (centripetal) obesity, thin extremities, supraclavicular 
fat pads,
posterior cervical fat (“buffalo hump”), “moon facies”
• hypertension
skin
• thin skin, facial plethora, hirsutism in women, wide purple 
striae,
acne, easy bruising, poor wound healing, mucocutaneous
candidiasis
musculoskeletal
• osteoporosis, pathologic fractures, avascular necrosis (AVN)
• proximal muscle weakness (more prominent in lower limbs)J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
2) Hyperfunction of adrenal glands: 
hypercortisolism. Clinical Features
neuropsychiatric
• emotional lability, depression, euphoria, frank psychosis
gonadal dysfunction
• oligomenorrhea / amenorrhea in women, decreased 
libido / impotence in men
metabolic
• glucose intolerance (frank diabetes less common), 
hyperlipidemia, polyuria, nephrocalcinosis
ectopic ACTH production
• hyperpigmentation, hypertension, hypokalemic
metabolic alkalosis,
weight loss, weakness (typical features of Cushing’s 
syndrome usually absent)
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
2) Hyperfunction of adrenal glands:  
hypercortisolism
Diagnosis of hypercortisolism ?
2) Hyperfunction of adrenal glands: 
hypercortisolism. Differential diagnosis
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
2)Hyperfunction of adrenal glands: 
hypercortisolism. Cushing’s syndrome . Diagnosis
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
Circadian Rhythm of Plasma Cortisol 2.6
 In normal subjects, plasma cortisol levels are at their highest 
early in the morning and reach a nadir (<50 nmol/L [<2 µg/dL] in 
a nonstressed subject) at about midnight
 This circadian rhythm is lost in patients with Cushing’s 
syndrome: the 9 a.m. plasma cortisol is normal but nocturnal 
levels are raised
 Midnight cortisol level greater than 200 nmol/L (>7.5 µg/dL) 
indicates Cushing’s syndrome
 Patients should be hospitalized for 24 to 48 hours before the 
midnight cortisol level is measured
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Urinary Free Cortisol Excretion
 Normal values are less than 220 to 330 nmol/24 hours (80 
to 120 µg/24 hours), depending on the assay used
 Patients should make two or three complete consecutive 
collections to account for patient error in collecting 
samples and for episodic cortisol secretion, notably from 
adrenal adenomas
2) Hyperfunction of adrenal glands:  
hypercortisolism. Cushing’s syndrome. Diagnosis
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Low-Dose Overnight Dexamethasone Suppression Tests
 In normal subjects, the administration of a supra-
physiologic dose of glucocorticoid results in suppression of
ACTH and cortisol secretion
 In Cushing’s syndrome of whatever cause, there is a failure
of this suppression when low doses of the synthetic
glucocorticoid dexamethasone are given
 1 mg of dexamethasone is given at mid-night or 0.5mg
every 6 hours. A normal response is a plasma cortisol level
of less than 140 nmol/L (<5 µg/dL) between 8 and 9 a.m.
the following morning
2) Hyperfunction of adrenal glands: 
hypercortisolism.  Cushing’s syndrome. Diagnosis 
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Computed Tomographic and Magnetic Resonance Imaging 
Scanning of Pituitary and Adrenals
Pituitary MRI is the investigation of choice when the biochemical tests 
suggest Cushing's disease
Abdominal CT scans
revealed a left
adrenal oval-shaped
mass (red X) in
coronal (c) and axial
images (d)
Hyperfunction of adrenal glands: hypercortisolism.  
Cushing’s syndrome. Imaging
J. Larry Jameson et. Endocrinology: ADULT & 
PEDIATRIC 7th ed., 2015
Bone abnormalities in Cushing’s disease
Aseptic necrosis of
the right humeral
head in a 43-year-
old woman with
Cushing’s disease of
about 8 months’
duration
Aseptic necrosis of
the right femoral
head in a 24-year-
old woman with
Cushing’s disease
of about 4years’
duration. The
arrows indicate the
crescent
subchondral
radiolucency, best
seen in this lateral
view.
diffuse
osteoporosis,
vertebral
collapse, and
subchondral
sclerosis in the
same patient
rib fracture in a
38-year-old man
with Cushing’s
disease.
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Hyperfunction of adrenal glands: 
hypercortisolism. Treatment : general 
approaches
Pituitary
• transsphenoidal resection, with glucocorticoid supplement peri- and 
post-operatively
• irradiation: only 50% effective, with significant risk of hypopituitarism
Adrenal
• adenoma: unilateral adrenalectomy (curative)
• carcinoma: palliative (frequent metastases, very poor prognosis)
adjunctive chemotherapy often not useful
Ectopic ACTH tumour - usually bronchogenic cancer (a paraneoplastic 
syndrome)
• chemotherapy/radiation for primary tumour
• agents blocking adrenal steroid synthesis: metyrapone or ketoconazole
• poor prognosis
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Options of treatment in case of Cushing 
syndrome?
From what to start?
2) Hyperfunction of adrenal glands 
hypercortisolism
2) Hyperfunction of adrenal glands: 
hypercortisolism. Cushing's Syndrome. Treatment 
Adrenal Causes
 adrenal adenomas should be removed by unilateral
adrenalectomy
 suboptimal replacement therapy with dexamethasone at
0.5 mg in the morning, with intermittent measurement of
morning plasma cortisol before taking dexamethasone till
180 nmol/L (6 µg/dL)
 patients should carry Steroid Alert card and increase their
dose of replacement therapy in the event of an intercurrent
illness
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2) Hyperfunction of adrenal glands: 
hypercortisolism. Cushing's Syndrome. Treatment
Pituitary-Dependent Cushing's Syndrome
 selective removal of a pituitary microadenoma
 postoperatively, hydrocortisone can be withdrawn to
maintenance replacement doses, usually within 3 to 7
days
 on day 5 postoperatively, plasma cortisol should be
measured at 9 AM with the patient having omitted
hydrocortisone for 24 hours
 plasma cortisol levels are less than 30 nmol/L (1
µg/dL) postoperatively - glucocorticoid replacement
therapy
www.slideshare.net/…nmn/oxford-american-handbook...
If surgical treatment is not possible or 
contraindicated what to do?
2) Hyperfunction of adrenal glands: 
hypercortisolism
2) Hyperfunction of adrenal glands: 
hypercortisolism. Cushing's Syndrome. Treatment
 Metyrapone - inhibits 11-hydroxylase to lower cortisol
concentrations prior to definitive therapy or while awaiting
benefit from pituitary radiation from 250 mg twice daily to
1.5 g every 6 hours
 Aminoglutethimide - blocks earlier enzymes in the
steroidogenic pathway and thus affects the secretion of
steroids - in doses of 1.5 to 3 g daily (start with 250 mg
every 8 hours)
 Ketoconazole - blocks a variety of steroidogenic
cytochrome P450dependent enzymes and thus lowers
plasma cortisol levels - 400 to 800 mg daily
www.slideshare.net/…nmn/oxford-american-handbook...
3) Acute insufficiency of  adrenal glands 
(acute adrenal crisis)
What is Adrenal crisis?
Adrenal crisis etiology
3) Acute insufficiency of  adrenal glands 
(acute adrenal crisis). Etiology
Inability to secrete increased cortisol, ACTH in response to 
stress (e.g. infection, dehydration, surgery)
• Acute decompensation of Addison’s disease due to 
infections, surgery etc
• 2-sided adrenalectomy due to Cushing disease
• Aplasia of adrenal glands
• Mts of tumor to adrenal gland
• Dysfunction of adrenal cortex due to severe stress
• Central nervous system disorders: tumors, meningitis,
encephalitis etc.
• Waterhouse – Fridrecsen syndrome – acute adrenal crisis
due to hemorrhage
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3) Acute insufficiency of  adrenal glands (acute 
adrenal crisis)
Clinical features of acute adrenal crisis    
3) Acute insufficiency of  adrenal glands :
Adrenal crisis. Clinical features
 Shock  
 Hypotension (often not responding to measures such as 
inotropic support)  
 Abdominal pain (may present as acute abdomen)  
 Unexplained fever  
 Often precipitated by major stress such as severe bacterial 
infection, 
 major surgery, unabsorbed glucocorticoid medication due 
to vomiting  
 Occasionally occurs due to bilateral adrenal infarction 
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
3) Acute insufficiency of  adrenal glands:
Adrenal crisis. Clinical features
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3) Acute insufficiency of  adrenal glands:
Adrenal crisis. Clinical features (Clinical forms)
1. Cardio-vascular
- Collapse
- Hypotension
- Cyanosis
- Hypothermia
- Cardiac failure
2. gastro-intestinal
- Nausea
- Vomiting
- Acute abdominal pain
- Diarrhea
3. Neurogenic
- Brain 
edema
- Astenia
- Depression
- Seizure
- Catatonia 
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3) Acute insufficiency of  adrenal glands (acute 
adrenal crisis)
How you will treat it?
3) Acute insufficiency of  adrenal glands :
Adrenal crisis. Treatment
Emergency management of acute adrenal 
insufficiency   
 This is a life-threatening emergency and should be treated 
if there is strong clinical suspicion, rather than waiting for 
confirmatory test results
 Blood should be taken for urgent analysis of electrolytes 
and glucose, in addition to cortisol and ACTH
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3) Acute insufficiency of  adrenal glands:
Adrenal crisis. Treatment
Fluids
 Large volumes of 0.9% saline may be required to reverse 
the volume depletion and sodium deficiency
 Several liters may be required in the first 24–48 hours, but 
caution should be exercised where there has been  chronic 
hyponatremia; in this circumstance rapid correction of the 
deficit exposes the patient to risk of central pontine 
myelinolysis
 If plasma sodium is <120 mmol/L at presentation, aim to 
correct this by no more than 10mmol/L in the fi rst 24 
hours
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3) Acute insufficiency of  adrenal glands: 
Adrenal crisis. Treatment
Hydrocortisone 
 A bolus dose of 100 mg hydrocortisone is administered 
intravenously
 Hydrocortisone 100 mg IM is then continued 6-hourly for 
24–48 hours or until the patient can take oral therapy
 Double replacement dose hydrocortisone (20, 10, and 10 
mg orally) can then be instituted until well
 This traditional regimen causes supraphysiological
replacement, and some authors suggest lower doses, e.g., 
150 mg IV/24 hours
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3) Acute insufficiency of  adrenal glands: 
Adrenal crisis. Treatment
Glucose supplementation   
 Occasionally, this is required because of risk of 
hypoglycemia (low glycogen stores in the liver as a result of 
glucocorticoid deficiency)
Investigate and treat precipitant   
 This is often infection
Monitoring treatment
 Monitor electrolytes, glucose, and urea
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4) Hormonally active adrenal tumors: 
Pheochromocytoma
What is Pheochromocytoma?
4) Hormonally active adrenal tumors 
Pheochromocytomas
 Pheochromocytomas are tumors of neuroectodermal origin 
arising from chromaffin cells
 The name pheochromocytoma, proposed by Pick in 1912, 
comes from the Greek words phaios (“dusky”) and chroma
(“color”); it refers to the staining that occurs when the 
tumors are treated with chromium salts
 The first diagnosis of pheochromocytoma was made in 
1886 by Frankel, who found bilateral tumors of the adrenal 
gland at autopsy in an 18-year-old girl who had died 
suddenly
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4) Hormonally active adrenal tumors
Pheochromocytomas.  Key features
 rare tumour arising from chromaffin cells of the 
sympathetic system
 most commonly a single tumour of adrenal medulla
 10% extra-adrenal, 10% multiple tumours, 10% malignant, 
10% familial
 tumour not innervated but via unknown mechanism, able 
to synthesize and release catecholamines
 cases sporadic or part of MEN (Multiple Endocrine 
Neoplasia )
 rare cause of hypertension (< 0.1% of all hypertensives)
 curable if recognized and properly treated, but fatal if not
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Does a pheochromocytoma tumour
always occur in the adrenal gland?
4) Hormonally active adrenal tumors: 
Pheochromocytoma
 No
 Pheochromocytomas typically arise in about 80% to
85% of cases from adrenal medullary chromaffin
tissue (also designated adrenal paragangliomas) and
in about 15% to 20% of cases from extra-adrenal
chromaffin tissues
 Those arising from extra-adrenal chromaffin tissue
are commonly referred to as paragangliomas
 Extra-adrenal pheochromocytomas arise mainly from
chromaffin tissue adjacent to sympathetic ganglia in
the abdomen, less commonly from the pelvis, and
rarely from the mediastinum
4) Hormonally active adrenal tumors
Pheochromocytomas. Localizations
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What clinical signs would you look for during 
physical examination?
4) Hormonally active adrenal tumors: 
Pheochromocytoma
4) Hormonally active adrenal tumors
Pheochromocytoma. Clinical signs
 symptoms are often paroxysmal, may be triggered by stress, 
exertion, certain foods
 hallmark is paroxysmal or sustained HTN (sustained HTN 
more common, present between attacks in 60% of patients)
 classic triad: “pounding” headache, palpitations, diaphoresis
 others: tremor, anxiety, chest or abdominal pain, nausea / 
vomiting,  weight loss, pallor, fever, tremor, tachyarrhythmias, 
pulmonary edema, diabetes mellitus 
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What test would you request?
4) Hormonally active adrenal tumors: 
Pheochromocytoma
4) Hormonally active adrenal tumors
Pheochromocytoma. Diagnosis
 Expert recommendations for initial biochemical testing 
from the International Symposium on Pheochromocytoma
include measurements of fractionated metanephrines in 
urine or plasma, or both, as available
 Three 24-h urine collections for catecholamine and 
metanephrine measurement
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4) Hormonally active adrenal tumors
Pheochromocytoma. Diagnosis
Catecholamine Testing 
• A fractionated plasma free metanephrine level may be
measured in a standard venipuncture sample, drawn about
15–20 minutes after intravenous catheter insertion
• Due to the episodic nature of the disease, plasma levels of
catecholamines can be normal and, therefore,
measurement of these hormones in the urine is more
reliable (two to three collections are necessary)
• Perform a 24-hour urine collection for creatinine, total
catecholamines, vanillylmandelic acid, and metanephrines.
Measure creatinine in all collections of urine to ensure
adequacy of the collection
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4) Hormonally active adrenal tumors
Pheochromocytoma. Diagnosis
 The collection container should be dark and acidified and 
should be kept cold to avoid degradation of the 
catecholamine
 Optimally, collect urine during or immediately after a crisis. 
Although dopamine is a major catecholamine, 
measurement of dopamine levels in 24-hour urine is not 
useful, because most urinary dopamine is derived from 
renal extraction
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What other blood test(s) may help you to 
confirm your suspicion?
4) Hormonally active adrenal tumors
4) Hormonally active adrenal tumors
Pheochromocytoma. Other blood tests
 The clonidine suppression test - when the suspicion of 
pheochromocytoma is high but the basal catecholamine 
levels are not diagnostic, a decrease in basal plasma 
catecholamines by 50% or less than 3 nmol/L (500 pg/mL) 
is expected 2 to 3 hours after 0.3 mg of clonidine is 
administered
 Clonidine it is a centrally acting α2-adrenergic agonist that 
suppresses central sympathetic nervous outflow; this 
normally results in lowered levels of plasma 
catecholamines in patients with-out pheochromocytoma
but no change in those with the tumor
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4) Hormonally active adrenal tumors
Pheochromocytoma. Other blood tests
 Blood is drawn for plasma catecholamines before and 3 
hours after the oral administration of clonidine 0.3 mg/70 
kg of body weight
 NANETS guidelines recommend clonidine suppression 
testing when plasma metanephrine values are less than 4-
fold above the upper reference limit
 The clonidine suppression test is unreliable in patients with 
normal or only mildly increased plasma catecholamine 
levels
 In such patients, normal suppression of plasma 
norepinephrine may occur after administration of clonidine
despite the presence of a pheochromocytoma
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4) Hormonally active adrenal tumors
Instrumental Diagnosis of 
Pheochromocytoma
CT Scanning 
Abdominal CT scanning has
an accuracy of 85-95% for
detecting adrenal masses
with a spatial resolution of 1
cm or greater but is less
accurate for lesions smaller
than 1 cm.
MRI 
is preferred for detection of
pheochromocytoma in children
and in pregnant or lactating
women. MRI has a reported
sensitivity of up to 100% in
detecting adrenal
pheochromocytomas, does not
require contrast, and does not
expose the patient to ionizing
radiation.
Scintigraphy
is reserved for cases in
which a pheochromocytoma
is confirmed biochemically
but CT scanning or MRI
does not show a tumor.
A 53-year-old man with uncontrolled
hypertension and catecholamine hypersecretion,
suspected for pheochromocytoma. 123I-MIBG
composite (A) anterior and (B) posterior whole-
body images at 24 hours postinjection show
focal intense activity in the region of the left
adrenal gland (arrow).
a left adrenal pheochromocytoma with intense
123I-MIBG uptake (arrowheads). There is also
pre-aortic soft tissue nodule with intense 123I-
MIBG uptake (arrows) on the SPECT/CT that
may represent an extraadrenal paraganglioma or
less likely a metastatic retroperitoneal lymph node
indicating malignant disease.
Functional ImagingAnatomic Imaging
J. Larry Jameson et. Endocrinology: ADULT & PEDIATRIC 7th ed., 2015
4) Hormonally active adrenal tumors
How is   Pheochromocytoma
treated ?
 The patient is found to
have a large left adrenal
tumour measuring 5 cm in
diameter
 The surgeon would like to
immediately remove the
tumour
Do you agree?
No, because a surgical
procedure in a patient
with a
pheochromocytoma may
precipitate a hypertensive
crisis
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4) Hormonally active adrenal tumors
Pheochromocytoma. Treatment
4) Hormonally active adrenal tumors
Pheochromocytoma. Treatment
 Surgical intervention in patients with pheochromocytomas
or hormonally functional parangangliomas should in all 
cases only be performed after preoperative blockade of 
effects of catecholamines, ideally with alpha-
adrenoreceptor blockers (e.g., phenoxybenzamine) 
administered for 7 to 14 days before surgery to normalize 
blood pressure
J. Larry Jameson et. Endocrinology: ADULT & 
PEDIATRIC 7th ed., 2015
Proposed algorithm for the preoperative treatment of patients
with pheochromocytoma. 2.3
Start alpha blockade with phenoxybenzamine 10–14 days preoperatively to allow for expansion of
blood volume. The patient should undergo volume expansion with isotonic sodium chloride solution.
Encourage liberal salt intake. Initiate a beta blocker only after adequate alpha blockade (usually, 2
days). Administer the last doses of oral alpha and beta blockers on the morning of surgery.
J. Larry Jameson et. Endocrinology: ADULT & 
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 Control of postoperative hypotension
 The volume of fluid required is often large (0.5 to 1.5 times 
the patient’s total blood volume) during the first 24 to 48 
hours after removal of the tumor
 This is because the half-lives of both metyrosine and 
phenoxybenzamine are approximately 12 hours, and thus 
it takes nearly three half-lives or 36 hours for the 
sympathetic nervous system to resume autoregulation
 When this occurs, renal output begins to increase, and 
blood pressure and heart rate remain stable 
 Postoperative hypertension may mean that some tumor 
tissue was not resected
4) Hormonally active adrenal tumors
Pheochromocytoma. Treatment
J. Larry Jameson et. Endocrinology: ADULT & 
PEDIATRIC 7th ed., 2015
Omar, who is 26 years old, is seen by his GP because of
recurrent headaches and generally feeling unwell. His
blood pressure was found to be elevated at 195/100.
The patient tells you that for the past 6 months, he has
been suffering from increased sweating and heat
intolerance, severe headaches and episodes of
palpitations associated with pallor
4) Hormonally active adrenal tumors
Pheochromocytoma. Clinical case
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From the history, what would you like to 
rule out as a cause for this patient’s 
hypertension?
4) Hormonally active adrenal tumors
Pheochromocytoma. Clinical case
 Clinical findings such as hypertension, headache, unusual
sweating, frequent arrhythmias, and the presence of pallor
during hypertensive episodes (so-called “spells”) are highly
suggestive of pheochromocytoma
4) Hormonally active adrenal tumors
Pheochromocytoma. Clinical case
J. Larry Jameson et. Endocrinology: ADULT & 
PEDIATRIC 7th ed., 2015
 Although headache, palpitations, and sweating are 
nonspecific symptoms, their presence in patients with 
hypertension should arouse immediate suspicion for a 
pheochromocytoma because this triad constitutes the most 
commonly encountered symptoms in patients with a 
pheochromocytoma
4) Hormonally active adrenal tumors
Pheochromocytoma
Clinical case
J. Larry Jameson et. Endocrinology: ADULT & 
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Clinical Endocrinology’ Tests
Test 1
A 43 year old female patient was delivered to the hospital 
in grave condition. She suffers from Addison’s disease. The 
patient had been regularly taking prednisolone but a week 
before she stopped taking this drug. Objectively: sopor, 
skin and visible mucous membranes are pigmented, skin 
and muscle turgor is lowered. Heart sounds are muffled, 
rapid. AP- 60/40 mm Hg, heart rate - 96/min. In blood: Na-
120 millimole/l, K- 5,8 micromole/l. Development of this 
complication is primarily caused by the deficit of the 
following hormone: 
 A. Cortisol
 B. Corticotropin (ACTH) 
 C. Adrenaline 
 D. Noradrenaline
 E. Adrostendion
Test 2
A 26-year-old patient complains about considerable 
muscle weakness, dizziness, extended abdominal pain, 
nausea and vomiting giving no relief. The disease has been 
gradually developing within 6 months. There was progress 
of general weakness, skin darkening. The patient fell into 
grave condition after an ARD: there appeared abdominal 
pain and frequent vomiting. Objectively: the skin is dry 
with diffuse pigmentation. Heart sounds are significantly 
weakened, heart rate - 60/min, AP- 80/40 mm Hg. The 
abdomen is slightly painful in the epigastrial region. In 
blood: WBCs - 8, 1 · 109/l, glucose - 3,0 millimole/l. What is 
the most likely diagnosis? 
 A. Chronic adrenal insufficiency. Addisonian crisis 
 B. Acute pancreatitis 
 C. Toxic infectious shock 
 D. Acute food poisoning 
 E. Acute cholecystitis
Test 3
After having the flu, a 39-year-old male patient with a 
history of Addison’s disease developed a condition 
manifested by weakness, depression, nausea, vomiting, 
diarrhea, hypoglycemia. AP-75/50 mm Hg.
Blood test results: low corticosterone and cortisol, 13-
oxycorticosteroids,  17-oxycorticosteroids levels. What 
condition developed in the patient?
 A. Acute adrenal insufficiency
 B. Acute gastritis
 C. Acute enterocolitis
 D. Collapse
 E. Diabetes mellitus
Test 4
After a holiday in the Crimea, a 49-year-old male patient 
with a history of lung tuberculosis felt increased weakness, 
periodic dizziness, easing bowel movements with 
abdominal pain, the need for additional salting his meals. 
The patient has noted that his condition improves after 
some sweet tea and validol taken sublingually. Objectively: 
there is an intense darkening of skin, AP- 70/50 mm Hg, 
glycemia is 3,0 mmol/l. What is the possible cause of health 
deterioration:
 A. Chronic adrenal insufficiency
 B. Diabetes mellitus
 C. Coronary artery disease
 D. Chronic pancreatitis
 E. Pulmonary tuberculosis
Test 5
A 32-year-old female complains of dizziness, headache, 
palpitation, tremor. For the lastseveralmonths shehas
beenunder outpatient observation for the increased 
arterial pressure. Since recently such attacks have become 
more frequent and severe. Objectively: skin is covered with 
clammy sweat, tremor of the extremities is present. HR-
110/min, AP- 220/140 mmHg. Heart sounds are muffled. 
Blood test results: WBCs - 9,8·109/l, ESR - 22 mm/h. Blood 
glucose - 9,8 millimole/l. What disease is the most likely 
cause of this crisis?
 A. Pheochromocytoma
 B. Essential hypertension
 C. Preeclampsia
 D. Primary hyperaldosteronism
 E. Diabetic glomerulosclerosis
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